{"transactions":[{"id":879707,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common  Stock","published_at":"2026-02-26T21:54:57.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":13700,"price":9.82,"value":134534.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2025."}],"balance_after":112982,"source":{"system":"sec-edgar","filing":"0001628280-26-012393","document":"wk-form4_1772142894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026012393/wk-form4_1772142894.xml","form_type":"4"}},{"id":879706,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common  Stock","published_at":"2026-02-26T21:54:57.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":3117,"price":9.5326,"value":29713.1142,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":126682,"source":{"system":"sec-edgar","filing":"0001628280-26-012393","document":"wk-form4_1772142894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026012393/wk-form4_1772142894.xml","form_type":"4"}},{"id":885002,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2026-02-25T00:10:42.000Z","date":"2026-02-22","kind":"grant","planned":true,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":110000,"derivative":{"exercise_price":7.56,"expiration_date":"2036-02-21","underlying":"Common  Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001628280-26-011328","document":"wk-form4_1771978240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011328/wk-form4_1771978240.xml","form_type":"4"}},{"id":885001,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common  Stock","published_at":"2026-02-25T00:10:42.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":4445,"price":7.4528,"value":33127.696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":129799,"source":{"system":"sec-edgar","filing":"0001628280-26-011328","document":"wk-form4_1771978240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011328/wk-form4_1771978240.xml","form_type":"4"}},{"id":885000,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common  Stock","published_at":"2026-02-25T00:10:42.000Z","date":"2026-02-22","kind":"grant","planned":true,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,034 shares of common stock acquired by the Reporting Person on November 28, 2025 pursuant to an employee stock purchase program."}],"balance_after":134244,"source":{"system":"sec-edgar","filing":"0001628280-26-011328","document":"wk-form4_1771978240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011328/wk-form4_1771978240.xml","form_type":"4"}},{"id":1004919,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common  Stock","published_at":"2025-11-07T20:27:52.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":2385,"price":5.16,"value":12306.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2024."}],"balance_after":78210,"source":{"system":"sec-edgar","filing":"0001628280-25-050592","document":"wk-form4_1762547269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025050592/wk-form4_1762547269.xml","form_type":"4"}},{"id":1008250,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common  Stock","published_at":"2025-11-05T00:40:39.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":1365,"price":5.863,"value":8002.995,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares of common stock acquired by the Reporting Person on May 30, 2025 pursuant to an employee stock purchase program."}],"balance_after":80595,"source":{"system":"sec-edgar","filing":"0001628280-25-049159","document":"wk-form4_1762303236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025049159/wk-form4_1762303236.xml","form_type":"4"}},{"id":1240776,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common  Stock","published_at":"2025-02-27T17:39:28.000Z","date":"2025-02-26","kind":"sale","planned":true,"acquired":false,"shares":7373,"price":9.1418,"value":67402.4914,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.03 to $9.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":79460,"source":{"system":"sec-edgar","filing":"0001628280-25-008499","document":"wk-form4_1740677961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025008499/wk-form4_1740677961.xml","form_type":"4"}},{"id":1246295,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2025-02-25T20:34:55.000Z","date":"2025-02-22","kind":"grant","planned":true,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":70000,"derivative":{"exercise_price":9.57,"expiration_date":"2035-02-21","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001628280-25-007690","document":"wk-form4_1740515688.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007690/wk-form4_1740515688.xml","form_type":"4"}},{"id":1246294,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common  Stock","published_at":"2025-02-25T20:34:55.000Z","date":"2025-02-24","kind":"sale","planned":true,"acquired":false,"shares":5140,"price":9.4534,"value":48590.476,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":86833,"source":{"system":"sec-edgar","filing":"0001628280-25-007690","document":"wk-form4_1740515688.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007690/wk-form4_1740515688.xml","form_type":"4"}},{"id":1246293,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common  Stock","published_at":"2025-02-25T20:34:55.000Z","date":"2025-02-22","kind":"grant","planned":true,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":91973,"source":{"system":"sec-edgar","filing":"0001628280-25-007690","document":"wk-form4_1740515688.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007690/wk-form4_1740515688.xml","form_type":"4"}},{"id":1342972,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common  Stock","published_at":"2024-12-04T20:35:53.000Z","date":"2024-12-02","kind":"sale","planned":false,"acquired":false,"shares":76,"price":8.2201,"value":624.7276,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sale instruction entered into on May 28, 2024, whereby shares purchased on November 29, 2024 pursuant to the Issuer's employee stock purchase program were automatically sold six months after the instruction date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects ownership after acquisition by the reporting person on November 29, 2024 of 76 shares of common stock pursuant to the Issuer's employee stock purchase program, and sale of such shares on December 2, 2024."}],"balance_after":56973,"source":{"system":"sec-edgar","filing":"0001628280-24-049897","document":"wk-form4_1733344540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024049897/wk-form4_1733344540.xml","form_type":"4"}},{"id":1372961,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common  Stock","published_at":"2024-11-08T00:20:55.000Z","date":"2024-11-06","kind":"sale","planned":true,"acquired":false,"shares":4397,"price":10.11,"value":44453.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2024."}],"balance_after":56973,"source":{"system":"sec-edgar","filing":"0001628280-24-046462","document":"wk-form4_1731025248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024046462/wk-form4_1731025248.xml","form_type":"4"}},{"id":1375519,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common  Stock","published_at":"2024-11-05T22:51:48.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":2347,"price":9.4696,"value":22225.1512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":61370,"source":{"system":"sec-edgar","filing":"0001628280-24-045387","document":"wk-form4_1730847101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024045387/wk-form4_1730847101.xml","form_type":"4"}},{"id":1375518,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":64498,"kind":"person","name":"de Verneuil Vanina","position":1,"cik":"0002036234","reported_name":"de Verneuil Vanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common  Stock","published_at":"2024-11-05T22:51:48.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":1403,"price":7.2039,"value":10107.0717,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":63717,"source":{"system":"sec-edgar","filing":"0001628280-24-045387","document":"wk-form4_1730847101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024045387/wk-form4_1730847101.xml","form_type":"4"}}]}